Spinach and Chive for Kidney Tubule Engineering: the Limitations of Decellularized Plant Scaffolds and Vasculature.


Journal

The AAPS journal
ISSN: 1550-7416
Titre abrégé: AAPS J
Pays: United States
ID NLM: 101223209

Informations de publication

Date de publication:
28 12 2020
Historique:
received: 29 09 2020
accepted: 08 12 2020
entrez: 28 12 2020
pubmed: 29 12 2020
medline: 28 9 2021
Statut: epublish

Résumé

Tissue decellularization yields complex scaffolds with retained composition and structure, and plants offer an inexhaustible natural source of numerous shapes. Plant tissue could be a solution for regenerative organ replacement strategies and advanced in vitro modeling, as biofunctionalization of decellularized tissue allows adhesion of various kinds of human cells that can grow into functional tissue. Here, we investigated the potential of spinach leaf vasculature and chive stems for kidney tubule engineering to apply in tubular transport studies. We successfully decellularized both plant tissues and confirmed general scaffold suitability for topical recellularization with renal cells. However, due to anatomical restrictions, we believe that spinach and chive vasculature themselves cannot be recellularized by current methods. Moreover, gradual tissue disintegration and deficient diffusion capacity make decellularized plant scaffolds unsuitable for kidney tubule engineering, which relies on transepithelial solute exchange between two compartments. We conclude that plant-derived structures and biomaterials need to be carefully considered and possibly integrated with other tissue engineering technologies for enhanced capabilities.

Identifiants

pubmed: 33369701
doi: 10.1208/s12248-020-00550-0
pii: 10.1208/s12248-020-00550-0
pmc: PMC7769781
doi:

Substances chimiques

Biocompatible Materials 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11

Références

Cell Tissue Res. 2010 Feb;339(2):449-57
pubmed: 19902259
Int J Mol Sci. 2017 Nov 26;18(12):
pubmed: 29186865
Tissue Eng Part A. 2019 Oct;25(19-20):1341-1346
pubmed: 31411111
Trends Biotechnol. 2020 Feb;38(2):178-190
pubmed: 31590907
Sci Rep. 2015 Nov 16;5:16702
pubmed: 26567716
Macromol Biosci. 2019 Feb;19(2):e1800412
pubmed: 30548802
J Vis Exp. 2018 May 31;(135):
pubmed: 29912197
Biomaterials. 2006 Jul;27(19):3675-83
pubmed: 16519932
Biomaterials. 2009 May;30(15):2899-911
pubmed: 19217158
PLoS One. 2016 Jun 21;11(6):e0157894
pubmed: 27328066
Int J Artif Organs. 2017 May 9;40(4):150-158
pubmed: 28430301
Br J Surg. 2020 Jun;107(7):793-800
pubmed: 32463143
Biomaterials. 2017 May;125:13-22
pubmed: 28222326
Adv Healthc Mater. 2017 Apr;6(8):
pubmed: 28319334
Front Bioeng Biotechnol. 2019 Mar 22;7:45
pubmed: 30968018
Adv Healthc Mater. 2013 Aug;2(8):1108-13
pubmed: 23554383
Innov Surg Sci. 2017 Jun 24;2(4):189-202
pubmed: 31579752
Sci Rep. 2016 May 31;6:26715
pubmed: 27242131
Nat Med. 2013 May;19(5):646-51
pubmed: 23584091
Biomaterials. 2013 Aug;34(24):5915-25
pubmed: 23680364
Int J Mol Sci. 2018 Dec 18;19(12):
pubmed: 30567407
Drug Metab Dispos. 2018 Sep;46(9):1338-1350
pubmed: 29980578
Pediatr Nephrol. 2014 Apr;29(4):519-24
pubmed: 23989397
PLoS One. 2014 May 19;9(5):e97835
pubmed: 24842603

Auteurs

Katja Jansen (K)

Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

Marianna Evangelopoulou (M)

Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

Carla Pou Casellas (C)

Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

Sarina Abrishamcar (S)

Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

Jitske Jansen (J)

Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, The Netherlands.
Department of Pediatric Nephrology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Amalia Children's Hospital, Nijmegen, The Netherlands.

Tina Vermonden (T)

Division of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

Rosalinde Masereeuw (R)

Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. r.masereeuw@uu.nl.
Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. r.masereeuw@uu.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH